Liver cancer is one of the leading causes of cancer-related mortality worldwide, and its development is strongly associated with chemical carcinogens such as diethylnitrosamine (DEN), which induce progressive hepatic injury and malignant transformation. Hence, investigating novel therapeutic agents is essential for developing effective treatment strategies. Aim: This study was designed to assess the expression of apoptosis regulators in the liver tissues of a rat model treated with DEN, and to assess the protective effects of green silver nanoparticles (AgNPs). Male Sprague- Dawley rats (~200g body weight) were equally distributed into four groups, including control, DEN-treated, Co-treated (DEN+ AgNPs), and AgNPs-treated groups. Histopathology, DNA isolation, and western blot analyses were performed. A Significant decrease in the body weight of DEN-treated rats was observed compared to the control group. DENtreated rats showed disruption of liver architecture with nodule formation and loss of the central vein. AgNPs co treatment showed recovery in body weight and attenuation of the histopathological lesions. Furthermore, damage in genomic DNA was detected with DEN treatment compared to the DEN+AgNPs and AgNPs groups. The expressions of Bax, p53, and Caspase-3 were downregulated, while Bcl-2 was upregulated with DEN treatment in the liver tissues of rats. The expressions of the targeted proteins were controlled with AgNPs treatment. The current results showed the regulatory role of AgNPs in apoptosis regulation in the liver tissues of DEN-exposed rats and its anticancer therapeutic potential.